Abstract
Abstract. Introduction. Endometriosis is a chronic estrogen-dependent disease characterized by the presence of endometrial-like tissue outside the uterine cavity and most often manifested by pelvic pain and infertility. It affects up to 10% of women of reproductive age, which is about 190 million women worldwide, and it is a serious medical and social issue. In the clinical context, it is advisable to search for biomarkers of the disease to ensure early noninvasive diagnosis. Current literature on potential biomarkers of endometriosis is already quite extensive. However, despite many publications, there is no consensus on and no similar approaches to defining such markers. Therefore, the search for potential biomarkers of endometriosis is still relevant. Aim: To summarize the information of contemporary literature on possible biomarkers of endometriosis that can be used in its early diagnosis and treatment. Materials and Methods. This is a review of publications based on search results in electronic resources in Russian and international systems, such as eLibrary, PubMed, MedLine, Crossref, etc., over the past 8 years (2015-2023). Results and Discussion. A constantly improving palette of the latest technologies that include and combine metabolomics, genomics, and proteomics, can be the key to success in finding reliable biomarkers. For such a complex and heterogeneous disease as endometriosis, a panel of biomarkers is likely to be more accurate than a single marker, both for the diagnosis and probably for helping classify subtypes of the disease. Conclusion. Current literature on potential biomarkers is quite extensive, but the desired result has not been achieved yet. Further research is needed.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.